🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsClinical Trials & ResearchClinicalTrials.gov GLP-1 trial tracker — updated weekly Page 10

ClinicalTrials.gov GLP-1 trial tracker — updated weekly

TrialTracker_MD Mon, Feb 26, 2024 at 4:00 PM 411 replies 11,865 viewsPage 10 of 20
DoseLogDan
Member
201
567
Feb 2025
Montana
Oct 18, 2024 at 10:00 AM#46
HPLC_Greg said:
Say what you would expect to see if you were wrong, before you look.

Genuinely useful, thank you. I had the facts and not the framework. Sending this to two other people who asked me the same thing last week.

Last edited: Oct 18, 2024 at 11:00 AM
45 18newstart_MO, mia_MS2, LeilaHI and 42 others
Reply Quote Save Share Report
TrialTracker_MD
Senior Member
2,345
15,678
Jan 2024
Maryland
Oct 26, 2024 at 7:07 PM#47

OP back with an update, since a thread like this is useless without one.

Update: the thing I was blaming turned out not to be the cause. Leaving the original post as written rather than editing it, so the mistake stays visible for whoever searches this next.

46 19stefan_berlin, Dr.EM_Chicago, pete_RVA and 43 others
Reply Quote Save Share Report
jennifer_SEA
Member
234
890
Nov 2024
Seattle, WA
Nov 4, 2024 at 4:09 AM#48
TrialTracker_MD said:
Update: the thing I was blaming turned out not to be the cause.

Adding a me-too, because a thread of one person's experience is not much use.

47 20matt_MKE, Dr.ReproEndo, lucas_SP_BR and 44 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
TinaHashiRN
Member
345
1,567
Sep 2024
Raleigh, NC
Nov 12, 2024 at 1:06 PM#49
TrialTracker_MD said:
Update: the thing I was blaming turned out not to be the cause.

There is a second half to this that has not been said yet. The useful move here is to separate what is established from what is widely repeated. Those two sets overlap less than the confident tone of most write-ups suggests, and the second set is where nearly all the disagreement on this board comes from.

48 21Admin, Dr.Martinez, mike_mod and 45 others
Reply Quote Save Share Report
quinn_sf
Member
489
2,123
Jun 2024
San Francisco, CA
Nov 20, 2024 at 9:58 PM#50

The figures, for anyone assembling their own picture. For anyone reading later: the numbers in this thread are worth checking against a primary source before you act on them, including mine. Half the figures circulating in this community trace back to a secondary summary that dropped a qualifier.

20 18Dr.EndoEP, GraceAZ_72, carl_compliance and 17 others
Reply Quote Save Share Report

Similar Threads

FLOW trial: semaglutide renal outcomes — NEJM publication review14 replies
SELECT trial: semaglutide 2.4mg cardiovascular outcomes — 4yr data9 replies
TRIUMPH program (retatrutide) — Phase 3 trial design and endpoints13 replies
Orforglipron ATTAIN trials — oral non-peptide GLP-1 agonist8 replies
CagriSema (amylin + semaglutide) — REDEFINE Phase 3 results20 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register